Neurotrope financials at a glance
| Year | Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | |||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0.68m | 0.72m | 0.91m | 6.73m | 7.9m | 12.92m | 13.07m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-5.53M | $-7.15M | $-10.32M | $-7.38M | $-10.99M | $-7.70M | $-11.89M | $0.00M | $0.00M | $-0.03M |
| FCF | Free Cash Flow |
|
$0.00M | $-7.20M | $-10.33M | $0.00M | $0.00M | $0.00M | $-11.90M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-8.16 | $-10.43 | $-12.37 | $-3.25 | $-1.43 | $-0.96 | $-0.92 | $0.00 | $0.00 | $0.00 |